6月25日消息阿斯利康近日宣布其与日本第一三共合作开发的精准治疗药物Datroway已获得美国监管部门批准用于治疗特定类

智通财经
25 Jun
6月25日消息阿斯利康近日宣布其与日本第一三共合作开发的精准治疗药物Datroway已获得美国监管部门批准用于治疗特定类型肺癌。阿斯利康表示这是该药物在肺癌领域获得的首个美国上市许可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10